Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: A new twist?

A new twist?

posted on Nov 19, 2008 10:32AM

Consider this. Perhaps Swartz wanted to limit his exposure, which he did. Perhaps holding on to a core number of shares, as we suspected, is in fact the case. What if Swartz is now actually buying? One might assume that he does have inside info. Would he run the price up? doubtful. Would he utilize his shares, as in Texas Hold Em, where you might bluff to get the opponent to lay down? Is he seilling, just to buy cheap? Hmmmmmmm Opty

Share
New Message
Please login to post a reply